Registration

LMH STRATEGIC SOLUTIONS for REGENXBIO INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues.

LobbyistCovered position, as disclosed
ALANNA TEMME New Legislative Director, U.S. Representative Jon Porter

Pharmacy PHA

Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues.

LobbyistCovered position, as disclosed
ALANNA TEMME New Legislative Director, U.S. Representative Jon Porter

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.